
Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
---|---|---|---|---|---|---|
09/30/2025 | Q3 | $761.4M | -- | -- | $0.90 | -- |
07/29/2025 | Q2 | $650.8M | -- | -- | $0.54 | -- |
04/28/2025 | Q1 | $678M | $685.7M | $0.61 | $0.62 | -$0.01 |
01/29/2025 | Q4 | $740.9M | $752.9M | $0.90 | $0.91 | -$0.01 |
10/23/2024 | Q3 | $715.6M | $737.3M | $0.89 | $0.79 | $0.10 |
07/24/2024 | Q2 | $701M | $729.9M | $1.14 | $0.77 | $0.37 |
04/25/2024 | Q1 | $570.4M | $599.8M | $0.40 | $0.33 | $0.07 |
01/30/2024 | Q4 | $677M | $670.6M | $0.72 | $0.72 | $0.00 |
10/25/2023 | Q3 | -- | -- | $0.78 | $0.73 | $0.05 |
07/26/2023 | Q2 | -- | -- | $0.73 | $0.66 | $0.07 |
04/26/2023 | Q1 | -- | -- | $0.50 | $0.44 | $0.06 |
01/25/2023 | Q4 | -- | -- | $1.04 | $0.75 | $0.29 |
10/25/2022 | Q3 | -- | -- | $1.10 | $1.04 | $0.06 |
07/26/2022 | Q2 | -- | -- | $1.16 | $1.14 | $0.02 |
04/26/2022 | Q1 | -- | -- | $0.92 | $0.89 | $0.03 |
01/26/2022 | Q4 | -- | -- | $1.29 | $1.29 | -$0.00 |
10/26/2021 | Q3 | -- | -- | $1.41 | $1.44 | -$0.03 |
07/27/2021 | Q2 | -- | -- | $1.76 | $1.75 | $0.01 |
04/27/2021 | Q1 | -- | -- | $1.09 | $1.05 | $0.04 |
01/27/2021 | Q4 | -- | -- | $1.05 | $1.01 | $0.04 |
10/20/2020 | Q3 | -- | -- | $1.21 | $1.12 | $0.09 |
07/21/2020 | Q2 | -- | -- | $1.05 | $1.03 | $0.02 |
04/21/2020 | Q1 | -- | -- | $0.97 | $0.87 | $0.10 |
01/22/2020 | Q4 | -- | -- | $0.75 | $0.79 | -$0.04 |
10/22/2019 | Q3 | -- | -- | $0.75 | $0.70 | $0.05 |
07/23/2019 | Q2 | -- | -- | $0.55 | $0.62 | -$0.07 |
04/23/2019 | Q1 | -- | -- | $0.62 | $0.44 | $0.18 |
01/23/2019 | Q4 | -- | -- | $0.79 | $0.51 | $0.28 |
10/23/2018 | Q3 | -- | -- | $0.63 | $0.63 | -$0.00 |
07/24/2018 | Q2 | -- | -- | $0.52 | -- | -- |
04/24/2018 | Q1 | -- | -- | $0.43 | -- | -- |
01/24/2018 | Q4 | -- | -- | -$0.54 | -- | -- |
10/26/2017 | Q3 | -- | -- | $0.52 | -- | -- |
07/26/2017 | Q2 | -- | -- | $0.87 | -- | -- |
04/26/2017 | Q1 | -- | -- | $0.42 | -- | -- |
01/25/2017 | Q4 | -- | -- | $0.33 | -- | -- |
10/26/2016 | Q3 | -- | -- | $0.31 | -- | -- |
07/27/2016 | Q2 | -- | -- | -$1.10 | -- | -- |
04/28/2016 | Q1 | -- | -- | $0.24 | -- | -- |
01/27/2016 | Q4 | -- | -- | -$0.00 | -- | -- |
10/28/2015 | Q3 | -- | -- | $0.34 | -- | -- |
Teradyne reported $685.7M worth of top line sales in its most recent quarter.
Teradyne announced earnings per share of $0.61 which represents a miss of analyst forecast a $0.62 per share.
Teradyne reported $415.3M that represents $2.56 per share over the last quarter.
Teradyne's earnings are forecast to grow from $3.32 per share to $3.18 per share next year representing an increase of 2.27%.
Teradyne's next earnings date is July 29, 2025.
Signup to receive the latest stock alerts
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Market Cap: $4.2T
P/E Ratio: 58x
Market Cap: $3.8T
P/E Ratio: 43x
Market Cap: $3.1T
P/E Ratio: 35x
SharpLink Gaming [SBET] is down 2.6% over the past day.
Exodus Movement [EXOD] is down 4.14% over the past day.
Unity Software [U] is up 7.51% over the past day.